actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
humira
abbott indonesia - indonesia - adalimumab - cairan injeksi - 40 mg
humira
abbott indonesia - indonesia - adalimumab - cairan injeksi - 40 mg/0,8 ml
xolair
novartis indonesia - indonesia - omalizumab - serbuk injeksi - 150 mg
xolair
novartis indonesia - indonesia - omalizumab - serbuk injeksi - 150 mg
simponi
tanabe indonesia - indonesia - golimumab - cairan injeksi - 50 mg/ 0,5 ml
simponi
tanabe indonesia - indonesia - golimumab - cairan injeksi - 50 mg/ 0,5 ml
simponi
mitsubishi tanabe pharma indonesia - indonesia - golimumab - injeksi - 50 mg
simponi
mitsubishi tanabe pharma indonesia - indonesia - golimumab - injeksi - 50 mg